1:49 PM
 | 
Mar 22, 2018
 |  BC Extra  |  Financial News

NMD raises €38M series A

NMD Pharma ApS (Aarhus, Denmark) raised €38 million ($46.6 million) in a tranched series A round led by new investor INKEF. Fellow new investor Roche Venture Fund and existing investors Novo Seeds and Lundbeckfonden Emerge also participated....

Read the full 161 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >